R-biopharm quote 818 item R7021 ridascreen gliadin competitive 2ND GEN
Ended Purchase Order Awarded
- Contract number
- HHSF223201510074P
- Awardee
-
R-Biopharm, Inc. UEI E9NXLK97A3Q3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $9,335
Award facts
- Contract value 100% obligated
- $9,335.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Summit, IL 60501, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSF223201510074P?
HHSF223201510074P was awarded to R-Biopharm, Inc. by Food and Drug Administration (Department of Health and Human Services) on February 5, 2015.
How much is contract HHSF223201510074P worth?
The government has obligated $9,335 on HHSF223201510074P.
Was contract HHSF223201510074P competed?
The extent of competition for HHSF223201510074P was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award